Basilea Pharmaceutica
Signal active
Organization
Contact Information
Overview
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the integrated research, development and commercial operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd., the company focuses on providing innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology, targeting the medical challenge of rising resistance and nonresponse to current treatment options.
About
Industries
Biotechnology, Pharmaceutical, Commercial
Founded
2000
Employees
101-250
Headquarters locations
Switzerland, Europe
Social
N/A
Profile Resume
Basilea Pharmaceutica headquartered in Switzerland, Europe, operates in the Biotechnology, Pharmaceutical, Commercial sector. The company focuses on Biotechnology and has secured $4.1B in funding across 48 round(s). With a team of 101-250 employees, Basilea Pharmaceutica is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Basilea Pharmaceutica, raised $900.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$84.7M
Details
0
Basilea Pharmaceutica has raised a total of $84.7M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Basilea Pharmaceutica is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Basilea Pharmaceutica | - | FUNDING ROUND - Basilea Pharmaceutica | 76.8M |
| Athyrium Capital Management LP | - | FUNDING ROUND - Athyrium Capital Management LP | 76.8M |
| Basilea Pharmaceutica | - | FUNDING ROUND - Basilea Pharmaceutica | 900.0K |
| CARB-X | - | FUNDING ROUND - CARB-X | 900.0K |
Recent Activity
There is no recent news or activity for this profile.